Case number 1:19-cv-10645
BAUSCH HEALTH IRELAND LIMITED et al v. ZYDUS PHARMACEUTICALS (USA), INC. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 5, 2019 | N/A | Terminated Case (0) Docket Text: ***Civil Case Terminated. (dmr) |
| Sep 4, 2019 | 14 | Order (2) Docket Text: LETTER ORDER Directing Plaintiffs to take the lead on coordinating the parties' meet and confer session(s), etc. Signed by Magistrate Judge Joel Schneider on 9/4/2019. (rss, ) |
| Sep 4, 2019 | 15 | Notice of Voluntary Dismissal (aty) (2) Docket Text: NOTICE of Voluntary Dismissal by ASSERTIO THERAPEUTICS INC., BAUSCH HEALTH IRELAND LIMITED (DENI, WILLIAM) |
| Sep 3, 2019 | 13 | Order Initial Scheduling Conference (Camden) (6) Docket Text: Order Initial Conference set for 10/16/2019 10:00 AM in Room 2060 before Magistrate Judge Joel Schneider.. Signed by Magistrate Judge Joel Schneider on 9/3/2019. (rss, ) |
| Aug 22, 2019 | 12 | Order (1) Docket Text: ORDER Directing Defendant Zydus Pharmaceuticals (USA) Inc. to answer by 9/23/2019. Signed by Magistrate Judge Joel Schneider on 8/22/2019. (rss, ) |
| Aug 21, 2019 | 11 | Letter (2) |
| Aug 21, 2019 | 11 | Text of Proposed Order (1) |
| Aug 21, 2019 | 11 | Main Document (2) Docket Text: Letter from Zydus Pharmaceuticals (USA) Inc.. (Attachments: # (1) Text of Proposed Order)(LI, ZHIBIN) |
| Aug 8, 2019 | N/A | Update Answer Due Deadline (0) Docket Text: Clerk's Text Order - The document [10] Application for Clerk's Order to Ext Answer/Proposed Order submitted by ZYDUS PHARMACEUTICALS (USA), INC. has been GRANTED. The answer due date has been set for 8/23/2019. (dmr) |
| Aug 7, 2019 | 9 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by ZHIBIN LI on behalf of ZYDUS PHARMACEUTICALS (USA), INC. (LI, ZHIBIN) |
| Aug 7, 2019 | 10 | Application for Clerk's Order to Ext Answer/Proposed Order (3) Docket Text: Application and Proposed Order for Clerk's Order to extend time to answer. (LI, ZHIBIN) |
| Aug 6, 2019 | 8 | Summons Returned Executed (3) Docket Text: SUMMONS Returned Executed by BAUSCH HEALTH IRELAND LIMITED, ASSERTIO THERAPEUTICS INC.. ZYDUS PHARMACEUTICALS (USA), INC. served on 7/19/2019, answer due 8/9/2019. (DENI, WILLIAM) |
| Apr 24, 2019 | N/A | Patent Pilot Reassignment (0) Docket Text: Text Minute Entry for proceedings held before Judge Michael A. Shipp: Pursuant to Local Patent Rule 1.5 Patent Pilot Project, case shall be reassigned to a designated patent judge. (gxh) |
| Apr 24, 2019 | 6 | Order Reassigning Case (2) Docket Text: ORDER REALLOCATING AND REASSIGNING CASE. Case Number 3:19-cv-10645. Case reallocated to Newark and reassigned to Judge Renee Marie Bumb and Magistrate Judge Joel Schneider for all further proceedings. Judge Michael A. Shipp, Magistrate Judge Douglas E. Arpert no longer assigned to case. Signed by Chief Judge Jose L. Linares on 4/24/2019. (jjc) |
| Apr 24, 2019 | 7 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by J. BRUGH LOWER on behalf of ASSERTIO THERAPEUTICS INC., BAUSCH HEALTH IRELAND LIMITED (LOWER, J.) |
| Apr 23, 2019 | N/A | Add and Terminate Judges (0) Docket Text: Judge Michael A. Shipp and Magistrate Judge Douglas E. Arpert added. (jmh) |
| Apr 23, 2019 | 4 | AO120 Patent/Trademark Form (1) Docket Text: AO120 Patent Form filed. (jmh) |
| Apr 23, 2019 | 5 | Summons Issued (2) Docket Text: SUMMONS ISSUED as to ZYDUS PHARMACEUTICALS (USA), INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jmh) |
| Apr 22, 2019 | 1 | Complaint (11) |
| Apr 22, 2019 | 1 | Exhibit 1 (10) |
| Apr 22, 2019 | 1 | Exhibit 2 (13) |
| Apr 22, 2019 | 1 | Exhibit 3 (15) |
| Apr 22, 2019 | 1 | Exhibit 4 (40) |
| Apr 22, 2019 | 1 | Civil Cover Sheet (1) |
| Apr 22, 2019 | 1 | L. Civ. R. 11.2 Certification (1) |
| Apr 22, 2019 | 2 | Corporate Disclosure Statement (aty) (1) Docket Text: Corporate Disclosure Statement by BAUSCH HEALTH IRELAND LIMITED identifying Bausch Health Companies Inc. as Corporate Parent.. (DENI, WILLIAM) |
| Apr 22, 2019 | 3 | Corporate Disclosure Statement (aty) (1) Docket Text: Corporate Disclosure Statement by ASSERTIO THERAPEUTICS INC. identifying BlackRock, Inc. as Corporate Parent.. (DENI, WILLIAM) |
| Apr 22, 2019 | 1 | Main Document (11) Docket Text: COMPLAINT against ZYDUS PHARMACEUTICALS (USA), INC. ( Filing and Admin fee $ 400 receipt number 0312-9602112), filed by BAUSCH HEALTH IRELAND LIMITED, ASSERTIO THERAPEUTICS INC.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Civil Cover Sheet, # (6) L. Civ. R. 11.2 Certification)(DENI, WILLIAM) |
| Apr 22, 2019 | 1 | Complaint* (1) |
